Ono Pharmaceutical Co Ltd
TSE:4528

Watchlist Manager
Ono Pharmaceutical Co Ltd Logo
Ono Pharmaceutical Co Ltd
TSE:4528
Watchlist
Price: 1 809 JPY -1.5% Market Closed
Market Cap: 849.6B JPY
Have any thoughts about
Ono Pharmaceutical Co Ltd?
Write Note

Ono Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ono Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Ono Pharmaceutical Co Ltd
TSE:4528
Cost of Revenue
-ÂĄ126.6B
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cost of Revenue
-ÂĄ1.5T
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Daiichi Sankyo Co Ltd
TSE:4568
Cost of Revenue
-ÂĄ416.7B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Otsuka Holdings Co Ltd
TSE:4578
Cost of Revenue
-ÂĄ639.6B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cost of Revenue
-ÂĄ337.2B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Astellas Pharma Inc
TSE:4503
Cost of Revenue
-ÂĄ383.6B
CAGR 3-Years
-16%
CAGR 5-Years
-6%
CAGR 10-Years
-2%

See Also

What is Ono Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-126.6B JPY

Based on the financial report for Jun 30, 2024, Ono Pharmaceutical Co Ltd's Cost of Revenue amounts to -126.6B JPY.

What is Ono Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%

Over the last year, the Cost of Revenue growth was -12%. The average annual Cost of Revenue growth rates for Ono Pharmaceutical Co Ltd have been -13% over the past three years , -8% over the past five years , and -14% over the past ten years .

Back to Top